The Latest Cardiac and Vascular News
CHICAGO–(BUSINESS WIRE)–Cardiosense, a digital health company pioneering AI-enabled solutions for cardiac disease management, today announced a new subgroup analysis of clinical data from the SEISMIC-HF I study at the Cardiovascular Research Foundation’s 2025 annual Transcatheter Cardiovascular Therapeutics® (TCT®) scientific symposium. The analysis examined the prescribed medications for symptomatic patients hospitalized with […]
Appointment highlights Cardiosense’s growth trajectory following FDA clearance, clinical milestones, and expanded leadership team CHICAGO–(BUSINESS WIRE)–Cardiosense, a digital health company pioneering AI-enabled solutions for cardiac disease management, today announced the appointment of Eric Meizlish as Chief Executive Officer (CEO). Meizlish, a seasoned healthcare technology executive with experience scaling innovative health platforms, will […]
The CardioTag device fuses multiple sensing modalities to capture unique insights about the relationship between cardiac mechanics, electrical impulses, and blood flow – valuable inputs that can be used by AI algorithms to assess cardiac pressures and volume status CHICAGO–July 29, 2025–Cardiosense, a medical AI company transforming cardiovascular disease management, […]
SEISMIC-HF II follows promising results from the peer-reviewed SEISMIC-HF I study, demonstrating accuracy of the Company’s non-invasive cardiac filling pressure algorithm comparable to that of FDA-approved implantable sensors CHICAGO – May 28, 2025 – Cardiosense, a medical AI company transforming cardiovascular disease management, today announced the launch of SEISMIC-HF II, […]
SEISMIC-HF I enrolled a large, demographically diverse population across 15 sites Results are an important step toward enabling widespread, non-invasive hemodynamic-guided heart failure management CHICAGO, Nov. 20, 2024 /PRNewswire/ — Cardiosense, a medical AI company transforming the…
CHICAGO, Oct. 28, 2024 /PRNewswire/ — Cardiosense, a digital health company developing heart failure management platforms for the early detection of worsening heart failure, today presented clinical data at the Cardiovascular Research Foundation’s 2024 annual Transcatheter Cardiovascular…
CHICAGO, Sept. 26, 2023 /PRNewswire/ — Cardiosense, a digital health company developing a non-invasive monitoring platform for the early detection of heart disease, recently started enrolling patients in SEISMIC-HF I, its nationwide clinical study to refine and validate algorithms to assess intracardiac filling pressure, an early physiological marker for acute heart failure […]
CHICAGO, Dec. 8, 2022 /PRNewswire/ — Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series A funding, co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint […]
